Doximity Inc

DOCS · NYSE · Healthcare / Health Information Services

33.34USD+0.14 (+0.42%)

Price History

Full chart

Market Stats

Previous Close33.20

Open33.51

Day Range32.79 – 33.71

52-Week Range17.15 – 58.24

Volume1.40M

Market Cap6.18B

P/E (TTM)40.79

Forward P/E24.21

EPS0.85

Dividend Yield0.00%

Beta1.29

50-Day Avg28.59

200-Day Avg25.46

About

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Company Details

SectorHealthcare
IndustryHealth Information Services
CEOMr. Jeffrey A. Tangney
Employees880
Headquarters500 3rd Street, San Francisco, CA, United States, 94107, USA
Websitehttps://www.doximity.com

Leadership

Mr. Jeffrey A. TangneyCo-Founder, CEO & Chairperson · b. 1973
Mr. Siddharth SitaramChief Accounting Officer · b. 1978
Mr. John T. VaughanGeneral Counsel, Corporate Secretary & Chief Compliance Officer · b. 1975
Dr. Steven L. Zatz M.D.President · b. 1957
Mr. Matthew SonefeldtCFO & Principal Financial Officer · b. 1980
Mr. Jey BalachandranChief Technology Officer
Mr. Perry Scott GoldHead of Investor Relations
Mr. Bruno MirandaSenior Vice President of Engineering
Mr. Joel DavisSenior Vice President of Product
Mr. Ben GreenbergSenior VP & GM Commercial Products

Financials

Income Statement

Currency: USD	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Total Revenue	85.69M	116.39M	206.90M	343.55M	419.05M	475.42M	570.40M	644.86M
Growth (%)	-	+35.82%	+77.76%	+66.05%	+21.98%	+13.45%	+19.98%	+13.05%
Cost of Revenue	10.89M	14.90M	31.20M	39.79M	53.49M	50.67M	55.87M	70.33M
Gross Profit	74.81M	101.49M	175.70M	303.76M	365.56M	424.75M	514.52M	574.54M
Gross Margin	87.29%	87.20%	84.92%	88.42%	87.24%	89.34%	90.20%	89.09%
Operating Expense	67.89M	79.33M	122.40M	190.22M	240.45M	260.88M	286.73M	359.62M
Operating Income	6.92M	22.16M	53.30M	113.54M	125.11M	163.88M	227.80M	214.92M
Operating Margin	8.08%	19.04%	25.76%	33.05%	29.86%	34.47%	39.94%	33.33%
EBITDA	7.47M	23.06M	57.50M	119.05M	143.44M	182.08M	240.76M	264.39M
EBITDA Margin	8.72%	19.82%	27.79%	34.65%	34.23%	38.30%	42.21%	41.00%
Net Income	7.83M	29.74M	50.21M	154.78M	112.82M	147.58M	223.19M	196.05M
Net Income Margin	9.14%	25.55%	24.27%	45.05%	26.92%	31.04%	39.13%	30.40%
R&D	27.50M	32.44M	43.87M	62.35M	80.19M	81.98M	93.04M	130.70M
R&D as % of Total Revenue	32.09%	27.87%	21.21%	18.15%	19.14%	17.24%	16.31%	20.27%
Interest Expense	1.01M	1.35M	4.47M	469.00K	8.05M	-	-	-
Interest Expense % of Total Revenue	1.18%	1.16%	2.16%	0.14%	1.92%	-	-	-

Balance Sheet

Currency: USD	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Total Assets	86.56M	138.92M	251.72M	991.36M	1.14B	1.08B	1.26B	1.12B
Total Liabilities	37.81M	137.78M	184.98M	112.76M	170.77M	177.98M	181.68M	172.85M
Total Equity	48.50M	1.14M	66.74M	878.59M	966.12M	901.40M	1.08B	950.84M
Cash	33.61M	48.43M	66.39M	112.81M	158.03M	96.78M	209.61M	219.18M
Total Debt	-	2.28M	1.25M	1.09M	15.64M	14.55M	12.40M	10.19M
Net Debt	-33.61M	-46.15M	-65.14M	-111.72M	-142.39M	-82.24M	-197.22M	-208.99M

Cash Flow

Currency: USD	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31	2025-03-31	2026-03-31
Operating Cash Flow	15.31M	26.20M	82.97M	126.58M	179.60M	184.10M	273.26M	326.46M
Investing Cash Flow	-9.07M	-13.10M	-70.42M	-640.57M	-59.92M	31.19M	-29.30M	147.17M
Financing Cash Flow	985.00K	1.72M	5.41M	560.41M	-74.46M	-276.52M	-131.14M	-464.06M
Capital Expenditure	1.19M	4.24M	4.61M	5.70M	6.18M	5.80M	6.53M	8.96M
Free Cash Flow	14.12M	21.95M	78.36M	120.88M	173.42M	178.29M	266.74M	317.50M
FCF to OCF	92.23%	83.80%	94.44%	95.50%	96.56%	96.85%	97.61%	97.25%

Earnings

Report Date	Mar 31, 2020	Dec 31, 2020	Mar 31, 2021	Jun 25, 2021	Aug 10, 2021	Nov 9, 2021	Feb 8, 2022	May 17, 2022	Aug 4, 2022	Nov 10, 2022	Feb 9, 2023	May 16, 2023	Aug 8, 2023	Nov 9, 2023	Feb 8, 2024	May 16, 2024	Aug 8, 2024	Nov 7, 2024	Feb 6, 2025	May 15, 2025	Aug 7, 2025	Nov 6, 2025	Feb 5, 2026	May 13, 2026	Aug 6, 2026	Nov 5, 2026
EPS Estimate	0.00	0.00	0.00	0.00	0.08	0.09	0.12	0.15	0.11	0.16	0.17	0.17	0.15	0.18	0.24	0.20	0.23	0.26	0.34	0.20	0.24	0.38	0.45	0.28	0.16	0.19
EPS Actual	-0.33	0.44	-0.09	0.06	0.11	0.19	0.29	0.21	0.14	0.17	0.22	0.20	0.19	0.22	0.29	0.25	0.28	0.30	0.45	0.32	0.27	0.45	0.46	0.26	0.14	-
Surprise	-	-	-	-	37.50%	111.11%	141.67%	40.00%	27.27%	6.25%	29.41%	17.65%	26.67%	22.22%	20.83%	25.00%	21.74%	15.38%	32.35%	60.00%	12.50%	18.42%	2.22%	-7.14%	-12.50%	-
Timing	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours

Key Statistics & Ratios

Market Cap6.18B

Enterprise Value5.13B

Trailing P/E40.79

Forward P/E24.21

PEG Ratio0.59

Price / Sales9.43

Price / Book6.34

EPS0.85

Book Value5.09

Revenue (TTM)655.57M

Gross Profit (TTM)577.34M

EBITDA208.40M

Profit Margin25.48%

Operating Margin21.54%

Return on Equity17.21%

Return on Assets10.95%

Shares Outstanding127.35M

Shares Float123.63M

Beta1.29

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Hold

Based on 21 analystsTarget 31.11

Strong Buy
3
Buy
5
Hold
11
Sell
1
Strong Sell
1

Ownership Breakdown

Institutions: 103.46%
Insiders: 2.98%
Retail / Other: 0.00%

Top Institutional Holders

BlackRock Inc
14.31M8.03%
Vanguard Portfolio Management, LLC
6.39M3.58%
Vanguard Capital Management, LLC
5.98M3.35%
D. E. Shaw & Co LP
5.92M3.32%
Two Sigma Investments LLC
4.65M2.61%
State Street Corp
4.21M2.36%
The Goldman Sachs Group Inc
4.09M2.29%
Geode Capital Management, LLC
3.85M2.16%
Wellington Management Company LLP
3.14M1.76%
Deutsche Bank AG
2.89M1.62%
Renaissance Technologies Corp
2.85M1.60%
BNP Paribas Arbitrage, SA
2.69M1.51%
Carmignac Gestion
2.36M1.32%
Federated Hermes Inc
2.33M1.31%
Morgan Stanley - Brokerage Accounts
2.25M1.26%
Loomis, Sayles & Company LP
2.19M1.23%
Squarepoint Ops LLC
2.17M1.22%

Top Fund Holders

iShares Core S&P Mid-Cap ETF
4.58M2.57%
Vanguard MStar Total Stk Mkt Idx Invest
3.87M2.17%
Vanguard Small Cap Index
2.72M1.53%